Journal article 785 views 98 downloads
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials
Subodh Verma,
Steve Bain ,
Julie Broe Honoré,
Johannes F. E. Mann,
Michael A. Nauck,
Richard E. Pratley,
Søren Rasmussen,
Maria Sejersten Ripa,
Bernard Zinman,
John B. Buse
Diabetes, Obesity and Metabolism, Volume: 22, Issue: 11
Swansea University Author: Steve Bain
-
PDF | Accepted Manuscript
Download (133.46KB)
DOI (Published version): 10.1111/dom.14140
Abstract
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials
Published in: | Diabetes, Obesity and Metabolism |
---|---|
ISSN: | 1462-8902 1463-1326 |
Published: |
Wiley
2020
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa54662 |
first_indexed |
2020-07-07T11:03:43Z |
---|---|
last_indexed |
2023-01-11T14:32:48Z |
id |
cronfa54662 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-12-02T18:45:48.4762304</datestamp><bib-version>v2</bib-version><id>54662</id><entry>2020-07-07</entry><title>Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-07-07</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>22</volume><journalNumber>11</journalNumber><paginationStart/><paginationEnd/><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1462-8902</issnPrint><issnElectronic>1463-1326</issnElectronic><keywords>cardiovascular disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy,macrovascular disease, type 2 diabetes</keywords><publishedDay>12</publishedDay><publishedMonth>8</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-08-12</publishedDate><doi>10.1111/dom.14140</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T18:45:48.4762304</lastEdited><Created>2020-07-07T12:00:19.5359779</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Subodh</firstname><surname>Verma</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author><author><firstname>Julie Broe</firstname><surname>Honoré</surname><order>3</order></author><author><firstname>Johannes F. E.</firstname><surname>Mann</surname><order>4</order></author><author><firstname>Michael A.</firstname><surname>Nauck</surname><order>5</order></author><author><firstname>Richard E.</firstname><surname>Pratley</surname><order>6</order></author><author><firstname>Søren</firstname><surname>Rasmussen</surname><order>7</order></author><author><firstname>Maria Sejersten</firstname><surname>Ripa</surname><order>8</order></author><author><firstname>Bernard</firstname><surname>Zinman</surname><order>9</order></author><author><firstname>John B.</firstname><surname>Buse</surname><order>10</order></author></authors><documents><document><filename>54662__17663__41e2df73bc5f4fd387f58084087b3b7a.pdf</filename><originalFilename>Verma2020.pdf</originalFilename><uploaded>2020-07-07T12:02:53.9069897</uploaded><type>Output</type><contentLength>136658</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2021-07-09T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>English</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2022-12-02T18:45:48.4762304 v2 54662 2020-07-07 Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2020-07-07 MEDS Journal Article Diabetes, Obesity and Metabolism 22 11 Wiley 1462-8902 1463-1326 cardiovascular disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy,macrovascular disease, type 2 diabetes 12 8 2020 2020-08-12 10.1111/dom.14140 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2022-12-02T18:45:48.4762304 2020-07-07T12:00:19.5359779 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Subodh Verma 1 Steve Bain 0000-0001-8519-4964 2 Julie Broe Honoré 3 Johannes F. E. Mann 4 Michael A. Nauck 5 Richard E. Pratley 6 Søren Rasmussen 7 Maria Sejersten Ripa 8 Bernard Zinman 9 John B. Buse 10 54662__17663__41e2df73bc5f4fd387f58084087b3b7a.pdf Verma2020.pdf 2020-07-07T12:02:53.9069897 Output 136658 application/pdf Accepted Manuscript true 2021-07-09T00:00:00.0000000 true English |
title |
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials |
spellingShingle |
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials Steve Bain |
title_short |
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials |
title_full |
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials |
title_fullStr |
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials |
title_full_unstemmed |
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials |
title_sort |
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials |
author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
author |
Steve Bain |
author2 |
Subodh Verma Steve Bain Julie Broe Honoré Johannes F. E. Mann Michael A. Nauck Richard E. Pratley Søren Rasmussen Maria Sejersten Ripa Bernard Zinman John B. Buse |
format |
Journal article |
container_title |
Diabetes, Obesity and Metabolism |
container_volume |
22 |
container_issue |
11 |
publishDate |
2020 |
institution |
Swansea University |
issn |
1462-8902 1463-1326 |
doi_str_mv |
10.1111/dom.14140 |
publisher |
Wiley |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2020-08-12T02:10:47Z |
_version_ |
1821369641596878848 |
score |
11.04748 |